about
Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLANaturally Occurring Hepatitis C Virus Subgenomic Deletion Mutants Replicate Efficiently in Huh-7 Cells and Are trans-Packaged In Vitro To Generate Infectious Defective ParticlesSurvival and hepatitis status among Asian Americans with hepatocellular carcinoma treated without liver transplantationTherapy and prognostic features of primary clear cell carcinoma of the liverTreatment of spontaneous ruptured hepatocellular carcinoma: A single-center study.Glo1 genetic amplification as a potential therapeutic target in hepatocellular carcinoma.A simulation shows that early treatment of chronic hepatitis B infection can cut deaths and be cost-effectiveDeclining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976-2005.Incidence and risk factors for hepatocellular carcinoma in Texas Latinos: implications for prevention research.Hepatitis B virus X protein upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinomaDisparities in hepatocellular carcinoma survival among Californians of Asian ancestry, 1988 to 2007.Liver cancer: Targeted future optionsDecreasing disparity in liver transplantation among white and Asian patients with hepatocellular carcinoma : California, 1998-2005.Inhibition of HCV 3a core gene through Silymarin and its fractions.Inhibition of hepatitis C virus 3a genotype entry through Glanthus Nivalis Agglutinin.Evaluation of total hepatocellular cancer lifespan, including both clinically evident and preclinical development, using combined network phenotyping strategy and fisher information analysis.Combination of macrophage inflammatory protein 1 alpha with existing therapies to enhance the antitumor effects on murine hepatomaInverse relationship between cirrhosis and massive tumours in hepatocellular carcinomaHepatitis B- and hepatitis C-related hepatocellular carcinomas in the United States: similarities and differencesTargeting blockage of STAT3 inhibits hepatitis B virus-related hepatocellular carcinomaHepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.Chemoembolization of hepatic malignancy.Prospective screening increases the detection of potentially curable hepatocellular carcinoma: results in 8,900 high-risk patients.Tumor factors associated with clinical outcomes in patients with hepatitis B virus infection and hepatocellular carcinoma.Rising incidence and demographics of hepatocellular carcinoma in the USA: what does it mean?Aberrant DNA methylation in hepatocellular carcinoma tumor suppression (Review).Primary pleomorphic liposarcoma of liver: a case report and review of the literature.Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?Irradiation-induced localization of IL-12-expressing mesenchymal stem cells to enhance the curative effect in murine metastatic hepatoma.Oridonin induces the apoptosis of metastatic hepatocellular carcinoma cells via a mitochondrial pathway.The healthcare burden imposed by liver disease in aging Baby Boomers.Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C.Predictors and Barriers to Hepatitis B Screening in a Midwest Suburban Asian Population.Hepatocellular Carcinoma and Viral Hepatitis in New York City.Reversible phospho-Smad3 signalling between tumour suppression and fibrocarcinogenesis in chronic hepatitis B infection.Infection with hepatitis C virus is an adverse prognostic factor after liver resection for early-stage hepatocellular carcinoma: implications for the management of hepatocellular carcinoma eligible for liver transplantation.Surveillance for hepatocellular carcinoma improves survival in Asian-American patients with hepatitis B: results from a community-based clinic.Serological markers of Hepatitis B and C among juvenile immigrants from Albania settled in Greece.SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection.Effect of mosapride citrate on gastric emptying in interferon-induced gastroparesis.
P2860
Q24672943-AFF31F0F-580D-4054-BC3C-C48205685A8EQ27489540-35B5F5BF-94FA-4686-823C-5616AB9D5DC3Q33405646-3019EC92-7239-4CD7-BD41-8F2D92E84F18Q33632378-0FE7D817-4728-4DFD-8431-6C15923C479FQ33722491-410B0E2C-7709-472C-87B0-789C9DC1ACB2Q33802709-5366B35A-35D8-4A1B-A72A-1A9F1E392CF3Q33804151-A9F53975-2653-4197-ACA1-3EB40EDD4993Q33816094-990498E6-3F74-43DE-B68E-5C6F24980B12Q34243903-3E2B0E4A-47D9-4D52-B4DA-CC47DAFF6617Q34359262-49BF2818-41E2-48A0-B02A-90236BFA7DE6Q34470706-C4431F68-8160-4870-BCB6-0DAD618BD118Q34695180-6A92CA6D-F607-4523-9A09-20DA03593367Q34789209-672CDE58-9561-4FC8-AE08-F8F8AD6D82E1Q34809056-D221946D-268C-412C-9B19-A54F74A12780Q35053124-502577CE-5896-4A8D-B11A-099FA02CA3C1Q35298123-7C4CF056-789A-4194-943B-20EF4C42E9FBQ36066995-7A6CF241-C7A5-446C-9D7A-C6F2AA6A1E1FQ36351992-29D8A1D7-EC26-4D64-A8D0-3311F645961CQ36454775-A49ACAA2-540D-4627-929C-EFCDF34F364FQ37013307-388D1706-3A83-4882-A5D3-368C91CA3824Q37157400-D51D9F84-E7B0-46AD-B837-86D45130B1E9Q37230931-EED44E75-9EDC-4E91-8ED4-BF2ECB16DEAFQ37350320-88689758-A22E-4322-B940-BEC486733A7BQ37677885-7575F8C2-8EBF-4B41-98F7-76C81ECA14B0Q37886161-91A68D8A-AEC5-4AB8-8481-7814854A23FAQ38239671-FD490E35-75B6-452A-AD83-5072E0844D6AQ38265530-40AC2BBA-73CE-4432-8EB8-BFBFF0214EE2Q38554626-B117695E-2156-4165-9C41-6E3176519E8AQ38914508-E04B94AA-B654-4C6B-951F-12C4B1CC5299Q39067978-002F1BCE-CC38-4E77-BB54-AFA0210C94F2Q39878799-65B4E5E3-AE6B-473D-9C02-106DB4C66DB9Q39984667-FD10D6AA-6606-45C1-9BE4-9C07C3379CF6Q40492422-ABE2954F-B26F-43C8-882D-6CC5BFBB84A8Q40554744-8B4B32E2-370C-4947-9D46-3FD83A6022F2Q42246559-13EBE900-82AA-4630-B1A8-B913E8F5A09AQ42988497-7AA2EC0C-665F-4DC7-AA89-1D7F609BAED4Q43230110-C293283C-4B42-4811-9230-1306E9A263BFQ44606357-FA25B634-794A-4840-BBE1-8DBAA5B68D53Q45355954-ABC2D1A9-A15C-4CC1-9379-F16FCD7A4E66Q50553074-2F918651-13D5-4549-966B-654872561A71
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Chronic viral hepatitis and hepatocellular carcinoma.
@ast
Chronic viral hepatitis and hepatocellular carcinoma.
@en
type
label
Chronic viral hepatitis and hepatocellular carcinoma.
@ast
Chronic viral hepatitis and hepatocellular carcinoma.
@en
prefLabel
Chronic viral hepatitis and hepatocellular carcinoma.
@ast
Chronic viral hepatitis and hepatocellular carcinoma.
@en
P2093
P1476
Chronic viral hepatitis and hepatocellular carcinoma.
@en
P2093
Jonathan R Hiatt
Myron J Tong
Yagil Barazani
P2888
P304
P356
10.1007/S00268-007-9041-3
P577
2007-06-01T00:00:00Z